US2006165731A1PendingUtilityA1
Vaccines
Est. expiryAug 18, 2006(expired)· nominal 20-yr term from priority
A61P 33/02Y10S435/947C12R 2001/90C12N 1/105A61K 39/012
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Vaccines active against coccidiosis in domestic fowls contain attenuated precocious strains of Eimeria species.
Claims
exact text as granted — not AI-modified1 . An attenuated anticoccidial vaccine containing live attenuated precocious lines of Eimeria acervulina, Eimeria maxima and Eimeria tenella , the number of sporulated oocysts of each separate Eimeria line present per 100 sporulated oocysts of Eimeria acervulina being for Eimeria maxima 15-30 and for Eimeria tenella 70-110.
2 . A vaccine as claimed in claim 1 containing, per 100 sporulated oocysts of Eimeria acervulina, 15-30 sporulated oocysts of a live attenuated precocious line of Eimeria brunetti, 180-220 sporulated oocysts of a live attenuated precocious line of Eimeria mitis , and 70-110 sporulated oocysts of a live attenuated precocious line of Eimeria necatrix.
3 . A vaccine as claimed in claim 2 containing 15-25 sporulated oocysts of a live attenuated precocious line of Eimeria praecox per 100 sporulated oocysts of Eimeria acervulina.
4 . A vaccine as claimed in claim 1 wherein the number of sporulated oocysts of each separate Eimeria line present per 100 sporulated oocysts of Eimeria acervulina is for Eimeria maxima 18-22 and for Eimeria tenella 75-105.
5 . A vaccine as claimed in claim 4 containing, per 100 sporulated oocysts of Eimeria acervulina, 18-22 sporulated oocysts of a live precocious, attenuated line of Eimeria brunetti, 190-210 sporulated oocysts of a live precocious attenuated line of Eimeria mitis and 75-105 sporulated oocysts of a live precocious attenuated line of Eimeria necatrix.
6 . A vaccine as claimed in claim 5 containing 18-22 sporulated oocysts of a live precocious attenuated line of Eimeria praecox per 100 sporulated oocysts of Eimeria acervulina.
7 . A live vaccine for use in combatting coccidiosis in chickens comprising an effective concentration of live sporulated oocysts of a strain of Eimeria acervulina having a prepatent time in chickens between 60 and 84 hours, of a strain of Eimeria maxima having a prepatent time in chickens of between 80 and 120 hours and of a strain of Eimeria tenella having a prepatent time in chickens between 90 and 125 hours.
8 . A vaccine as claimed in claim 7 additionally comprising an effective concentration of live sporulated oocysts of a strain of Eimeria necatrix having a prepatent time in chickens between 90 and 126 hours, of a strain of Eimeria mitis having a prepatent time in chickens between 60 and 84 hours and of a strain of Eimeria brunetti having a prepatent time in chickens between 70 and 100 hours.
9 . A vaccine as claimed in claim 8 additionally comprising an effective concentration of live sporulated oocysts of a strain of Eimeria praecox having a prepatent time in chickens between 44 and 75 hours.
10 . A vaccine as claimed in claim 1 in dosage unit form in which each dosage unit contains 50 to 25,000 of said oocysts of Eimeria acervulina, 10 to 5,000 of said oocysts of Eimeria maxima and 50 to 25,000 of said oocysts of Eimeria tenella.
11 . A vaccine as claimed in claim 2 in which each dosage unit contains 50 to 25,000 of said oocysts of Eimeria acervulina, 10 to 5,000 of said oocysts of Eimeria maxima, 50 to 25,000 of said oocysts of Eimeria teneila, 10 to 5,000 of said oocysts of Eimeria brunetti, 100 to 50,000 of said oocysts of Eimeria mitis and 50 to 25,000 of said oocysts of Eimeria necatrix.
12 . A vaccine as claimed in claim 3 in which each dosage unit contains 50 to 25,000 of said oocysts of Eimeria acervulina, 10 to 5,000 of said oocysts of Eimeria maxima, 50 to 25,000 of said oocysts of Eimeria tenella, 10 to 5,000 of said oocysts of Eimeria brunetti, 100 to 50,000 of said oocysts of Eimeria mitis, 50 to 25,000 of said oocysts of Eimeria necatrix , and 10 to 5,000 of said oocysts of Eimeria praecox.
13 . A vaccine as claimed in claim 1 in which the said Eimeria strains are stable after 5 passages in chickens without selection.
14 . A vaccine as claimed in claim 1 in which the said strain of Eimeria acervulina is E. acervulina ECACC 86072203, the said strain of Eimeria tenella is E. tenella ECACC 86072201 and the said strain of Eimeria maxima is E. maxima ECACC 86112011 and/or ECACC 86112012.
15 . A vaccine as claimed in claim 2 in which the said strain of Eimeria mitis is E. mitis ECACC 86072206, the said strain of Eimeria necatrix is E.necatrix ECACC 86072202 and the said strain of Eimeria brunetti is E. brunetti ECACC 86112013.
16 . A vaccine as claimed in claim 2 in which the said strain of Eimeria mitis is E. mitis ECACC 86072206, the said strain of Eimeria necatrix is E.necatrix ECACC 86072202 and the said strain of Eimeria brunetti is E. brunetti ECACC 86072204.
17 . A vaccine as claimed in claim 3 in which the said strain of Eimeria praecox is E. praecox ECACC 86072205.
18 . An attenuated precocious Eimeria strain selected from
E. acervulina
ECACC 86072203
E. brunetti
ECACC 86072204
E. brunetti
ECACC 86112013
E. maxima
ECACC 86112011
E. maxima
ECACC 86112012
E. mitis
ECACC 86072206
E. necatrix
ECACC 86072202
E. praecox
ECACC 86072205
E. tenella
ECACC 86072201
and precocious attenuated immunogenic mutants and variants thereof.
19 . A process for the preparation of a vaccine as claimed in claim 1 which comprises sporulating oocysts of the said Eimeria strains and admixing them with a carrier and/or adjuvant.
20 . A method of inhibiting coccidiosis in chickens which comprises administering to the chickens an effective amount of a vaccine as claimed in claim 1 .
21 . A method as claimed in claim 19 in which the vaccine is administered in the drinking water of the chickens.Join the waitlist — get patent alerts
Track US2006165731A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.